Science Explorer Back to mapMap
Institution · Iridium Kankernetwerk

Most cited papers from Iridium Kankernetwerk

What are the most cited papers from Iridium Kankernetwerk?

The most cited paper from Iridium Kankernetwerk is "Breast cancer" (Sibylle Loibl, Philip M. Poortmans, Monica Morrow et al., 2021), with 1,696 citations. Next come "Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation" (1,113) and "Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up" (991).

Showing 50 of 60 papers. Every paper with more than 73 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Breast cancer Sibylle Loibl, Philip M. Poortmans, Monica Morrow et al. · The Lancet 2 Apr 2021 1,696
2 Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation Matthias Gückenberger, Yolande N. Lievens, Angelique B. Bouma et al. · The Lancet Oncology Open access 2020 1,113
3 Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up Sibylle Loibl et al. · Annals of Oncology Open access 13 Dec 2023 991
4 Defining oligometastatic disease from a radiation oncology perspective: An ESTRO-ASTRO consensus document Yolande N. Lievens, Matthias Gückenberger, Daniel Richard Gomez et al. · Radiotherapy and Oncology Open access 22 Apr 2020 678
5 Relevance of a systematic geriatric screening and assessment in older patients with cancer: results of a prospective multicentric study Cindy Kenis, Dominique Bron, Yves Libert et al. · Annals of Oncology Open access 4 Jan 2013 340
6 Global cancer control: responding to the growing burden, rising costs and inequalities in access Gerald W. Prager et al. · ESMO Open Open access 2018 321
7 Overview of artificial intelligence-based applications in radiotherapy: Recommendations for implementation and quality assurance Liesbeth Vandewinckele, Michaël Claessens, Anna M. Dinkla et al. · Radiotherapy and Oncology Open access 10 Sep 2020 320
8 Internal mammary and medial supraclavicular lymph node chain irradiation in stage I–III breast cancer (EORTC 22922/10925): 15-year results of a randomised, phase 3 trial Philip M. Poortmans et al. · The Lancet Oncology Open access 2 Nov 2020 302
9 The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group Khalid El Bairi et al. · npj Breast Cancer Open access554 authors Dec 2021 288
10 European Society for Radiotherapy and Oncology Advisory Committee in Radiation Oncology Practice consensus recommendations on patient selection and dose and fractionation for external beam radiotherapy in early breast cancer Icro Meattini et al. · The Lancet Oncology Open access 30 Dec 2021 273
11 Automation in intensity modulated radiotherapy treatment planning—a review of recent innovations Mohammad Lutfi Hussein, Ben J.M. Heijmen, Dirk Verellen et al. · British Journal of Radiology Open access 3 Aug 2018 273
12 Long-Term Outcomes and Genetic Predictors of Response to Metastasis-Directed Therapy Versus Observation in Oligometastatic Prostate Cancer: Analysis of STOMP and ORIOLE Trials Matthew Pierre Deek et al. · Journal of Clinical Oncology Open access 24 Aug 2022 256
13 Understanding breast cancer complexity to improve patient outcomes: The St Gallen International Consensus Conference for the Primary Therapy of Individuals with Early Breast Cancer 2023 Giuseppe Curigliano et al. · Annals of Oncology Open access 6 Sep 2023 242
14 ESO–ESMO fifth international consensus guidelines for breast cancer in young women (BCY5) Shani Paluch–Shimon et al. · Annals of Oncology Open access 4 Aug 2022 234
15 Recommendations for triage, prioritization and treatment of breast cancer patients during the COVID-19 pandemic Giuseppe Curigliano, Maria João Cardoso, Philip M. Poortmans et al. · The Breast Open access 16 Apr 2020 233
16 The HILUS-Trial—a Prospective Nordic Multicenter Phase 2 Study of Ultracentral Lung Tumors Treated With Stereotactic Body Radiotherapy Karin Lindberg et al. · Journal of Thoracic Oncology Open access 3 Apr 2021 214
17 European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus on re-irradiation: definition, reporting, and clinical decision making Nicolaus H. Andratschke, Jonas Willmann, Ane Lindegaard Appelt et al. · The Lancet Oncology Open access 26 Sep 2022 212
18 Epidemiology of spinal metastases, metastatic epidural spinal cord compression and pathologic vertebral compression fractures in patients with solid tumors: A systematic review Ruben Van den Brande, Erwin M. J. Cornips, Marc Peeters et al. · Journal of bone oncology ReviewOpen access 9 Jul 2022 209
19 The requirements of a specialist breast centre Laura Biganzoli et al. · The Breast Open access 25 Feb 2020 201
20 Metastases-directed stereotactic body radiotherapy in combination with targeted therapy or immunotherapy: systematic review and consensus recommendations by the EORTC–ESTRO OligoCare consortium Stephanie G. C. Kroeze et al. · The Lancet Oncology ReviewOpen access 27 Feb 2023 181
21 ESMO Management and treatment adapted recommendations in the COVID-19 era: Breast Cancer Evandro de Azambuja, Dario Trapani, Sibylle Loibl et al. · ESMO Open Open access 2020 178
22 Radiotherapy to regional nodes in early breast cancer: an individual patient data meta-analysis of 14 324 women in 16 trials Carolyn W. Taylor et al. · The Lancet ReviewOpen access114 authors Nov 2023 170
23 Management of patients with advanced prostate cancer—metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 Silke Gillessen et al. · European Journal of Cancer Open access118 authors 2 Mar 2023 166
24 Professional burnout in European young oncologists: results of the European Society for Medical Oncology (ESMO) Young Oncologists Committee Burnout Survey Susana N. Banerjee, Raffaele Califano, Jesus Corral et al. · Annals of Oncology Open access 24 Apr 2017 145
25 Metastasis-directed Therapy in Treating Nodal Oligorecurrent Prostate Cancer: A Multi-institutional Analysis Comparing the Outcome and Toxicity of Stereotactic Body Radiotherapy and Elective Nodal Radiotherapy Elise De Bleser et al. · European Urology Open access 20 Jul 2019 143
26 Management of Patients with Advanced Prostate Cancer. Report from the 2024 Advanced Prostate Cancer Consensus Conference (APCCC) Silke Gillessen et al. · European Urology Open access121 authors 11 Oct 2024 133
27 The long- and short-term variability of breathing induced tumor motion in lung and liver over the course of a radiotherapy treatment Jennifer Dhont, Jef Vandemeulebroucke, M. Burghelea et al. · Radiotherapy and Oncology 12 Oct 2017 132
28 Management of Patients with Advanced Prostate Cancer: Report from the Advanced Prostate Cancer Consensus Conference 2021 Silke Gillessen et al. · European Urology Open access 18 Apr 2022 131
29 Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022 Silke Gillessen et al. · European Urology Open access118 authors 6 Dec 2022 123
30 Targeting brain metastases in breast cancer Chiara Corti, Gabriele Antonarelli, Carmen Criscitiello et al. · Cancer Treatment Reviews 16 Dec 2021 105
31 Laboratory-based surveillance for Cryptosporidium in France, 2006–2009 Collective The ANOFEL Cryptosporidium National Network · Eurosurveillance Open access 19 Aug 2010 104
32 Design, realization, and characterization of a novel diamond detector prototype for FLASH radiotherapy dosimetry Marco Marinelli, G. Felici, Federica Galante et al. · Medical Physics Open access 22 Jan 2022 103
33 Artificial Intelligence in magnetic Resonance guided Radiotherapy: Medical and physical considerations on state of art and future perspectives Davide Cusumano, Luca Boldrini, Jennifer Dhont et al. · Physica Medica Open access May 2021 103
34 Checkpoint Inhibitors in Combination With Stereotactic Body Radiotherapy in Patients With Advanced Solid Tumors Mathieu Spaas, Nora Sundahl, Vibeke Krüse et al. · JAMA Oncology Open access 6 Jul 2023 102
35 Recommendations for radiation therapy in oligometastatic prostate cancer: An ESTRO-ACROP Delphi consensus Thomas Zilli et al. · Radiotherapy and Oncology Open access 10 Oct 2022 102
36 Histopathological growth patterns of liver metastasis: updated consensus guidelines for pattern scoring, perspectives and recent mechanistic insights Emily Latacz et al. · British Journal of Cancer Open access Jun 2022 102
37 IL-15-secreting CAR natural killer cells directed toward the pan-cancer target CD70 eliminate both cancer cells and cancer-associated fibroblasts Astrid Van den Eynde et al. · Journal of Hematology & Oncology Open access 9 Feb 2024 101
38 FLASH radiotherapy with photon beams Pierre Montay‐Gruel, Stéphanie Corde, Jean Albert Laissue et al. · Medical Physics 14 Sep 2021 101
39 Joint EANM-SNMMI guideline on the role of 2-[18F]FDG PET/CT in no special type breast cancer Sofia Carrilho Vaz, J.P. Pilkington Woll, Fátima Cardoso et al. · European Journal of Nuclear Medicine and Molecular Imaging Open access 14 May 2024 98
40 Defining the role of real-world data in cancer clinical research: The position of the European Organisation for Research and Treatment of Cancer Robbe Saesen, Mieke Van Hemelrijck, Jan Bogaerts et al. · European Journal of Cancer Open access 21 Mar 2023 98
41 Development of an ultra‐thin parallel plate ionization chamber for dosimetry in FLASH radiotherapy Faustino Gómez, Diego Miguel González-Castaño, Nicolás Gómez Fernández et al. · Medical Physics Open access 13 Apr 2022 97
42 Changes in breast cancer management during the Corona Virus Disease 19 pandemic: An international survey of the European Breast Cancer Research Association of Surgical Trialists (EUBREAST) Maria Luisa Gasparri, Oreste ­Gentilini, Diana Lueftner et al. · The Breast Open access 29 May 2020 97
43 Breast cancer during pregnancy: epidemiology, phenotypes, presentation during pregnancy and therapeutic modalities Ingrid A Boere, Christianne Lok, Philip M. Poortmans et al. · Best Practice & Research Clinical Obstetrics & Gynaecology Open access 9 May 2022 93
44 Using PSMA imaging for prognostication in localized and advanced prostate cancer Matthew J. Roberts, Tobias Maurer, Marlon Perera et al. · Nature Reviews Urology Review 6 Dec 2022 90
45 ESTRO IORT Task Force/ACROP recommendations for intraoperative radiation therapy with electrons (IOERT) in breast cancer Gerd Fastner, Christoph Gaisberger, Julia Kaiser et al. · Radiotherapy and Oncology Open access 12 May 2020 90
46 ADT with SBRT versus SBRT alone for hormone-sensitive oligorecurrent prostate cancer (RADIOSA): a randomised, open-label, phase 2 clinical trial Giulia Marvaso et al. · The Lancet Oncology Mar 2025 89
47 International multidisciplinary consensus on the integration of radiotherapy with new systemic treatments for breast cancer: European Society for Radiotherapy and Oncology (ESTRO)-endorsed recommendations Icro Meattini et al. · The Lancet Oncology Open access 29 Jan 2024 88
48 The Efficacy and Safety of Metastasis-directed Therapy in Patients with Prostate Cancer: A Systematic Review and Meta-analysis of Prospective Studies Marcin Miszczyk et al. · European Urology ReviewOpen access 7 Nov 2023 88
49 Machine learning applications in radiation oncology: Current use and needs to support clinical implementation Charlotte L. Brouwer, Anna M. Dinkla, Liesbeth Vandewinckele et al. · Physics and Imaging in Radiation Oncology Open access Oct 2020 87
50 The combined presence of CD20 + B cells and PD-L1 + tumor-infiltrating lymphocytes in inflammatory breast cancer is prognostic of improved patient outcome Hugo Arias‐Pulido, Ashley Cimino‐Mathews, Nabila Chaher et al. · Breast Cancer Research and Treatment Open access Jun 2018 85

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.